Dr. Scott Sigman, founder and chief medical officer of OrthoLazer Orthopedic Laser Centers and host of the Ortho Show podcast, discusses current trends in arthroscopic sports medicine and orthopedic care in an in-depth interview with SmartTRAK.

In an interview with SmartTRAK, Scott Sigman, MD discusses many trends in arthroscopic technologies and soft tissue fixation including advancements in anterior cruciate ligament (ACL) repair with the BEAR Implant, graft selection in ACL reconstruction, the Stryker InSpace Balloon for massive rotator cuff tears, advancements in Latarjet, needle arthroscopy and more. Dr. Sigman is the chief medical officer and founder of OrthoLazer Orthopedic Laser Centers and the host of the Ortho Show podcast. 

To find out more about Dr. Sigman’s insights on sports medicine and arthroscopy, click on the following video to watch Andy Knapik, SmartTRAK's Sr. Analyst, Soft Tissue Fixation and Arthroscopic Enabling Technologies, interview Dr. Sigman (49:55 min). A complete transcript of the interview is available here. For more details, interview topics by timecode are provided below.

Headwinds persist for the Arthroscopic Technologies Market in Q322

With most of the major headwinds caused by COVID-19 in the rear-view mirror, the Arthroscopic Technologies (AT) Market showed growth in the third quarter with WW Arthroscopic Technologies revenues up +4.2% over Q321. The quarter saw a continued rise in procedural volumes globally that resulted in growth for the AT disposables market which trends with case volumes. On the capital side of the AT Market, capital spending and demand remained strong for items such as arthroscopic camera systems with new equipment purchases as well as an increasing need for replacement capital driving demand.

Among the many topics covered in detail in our comprehensive Q322 Arthroscopic Technologies Market Recap* are:

Soft Tissue Fixation Takes A Hit In Q421

After two quarters of significant growth, Soft Tissue Fixation took a hit in Q421, with another spike in COVID cases negatively affecting procedure volumes. 2021 was a year full of ups and downs due mainly to the COVID pandemic and Q4 was no different. COVID once again brought a new wave of cases, with the Omicron variant taking its toll on Soft Tissue Fixation case volumes resulting in modest YoY revenue declines over 2020.

Among the many topics covered in detail in our comprehensive Q421 Soft Tissue Fixation Market Recap* are:

Soft Tissue Fixation Continues to Pick Up Steam in Q2 2021

With the world trying to move past the negative impacts of COVID-19, the Soft Tissue Fixation market continued to make significant advancements in the second quarter of 2021. The quarter saw a continued rise in case volumes for elective sports medicine procedures worldwide driven primarily through market recovery in the wake of the COVID-19 pandemic. 

Among the many topics covered in detail in our comprehensive Q221 Soft Tissue Fixation Market Recap* are:

Arthroscopic Technologies starts to pick up speed in 2021

While the COVID pandemic was still slowing parts of the overall medical device market, the Arthroscopic Technologies market was able to start to pull ahead as case volumes for Arthroscopic Sports Medicine procedures started to climb back towards pre-COVID levels.

Among the many topics covered in the comprehensive Q121 Soft Tissue Fixation Market Recap* are:

Despite a spike in COVID cases, Soft Tissue Fixation was resilient and managed to ride out the COVID storm in Q420

While Q4 brought another surge of COVID cases worldwide, Soft Tissue Fixation was able to weather the storm with more resilience, resulting in YoY revenue declines but sequential revenue volume improvement over Q3.

Q4 saw an increase from the previous quarter and saw numbers that closely matched the same period in 2019. According to SmartTRAK Financial Dashboard, worldwide in Q4, the Soft Tissue Fixation market was down -1.7% YoY. At the regional level, US Soft Tissue Fixation ended Q4 near even from the previous year, down -0.2%. The EU and ROW finished Q4 with declines of -2.9% and -2.8% YoY respectively.

Among the many topics covered in the comprehensive Q420/FY20 Soft Tissue Fixation Market Recap* are: